investor groups & Funds

Venture Capital

Private Investment

Corporate Venture

Angel Groups

Family Offices

Project Medtech empowers accelerators and incubators through flexible engagement models, including entrepreneur-in-residence support and venture studio frameworks. We serve as a guiding light by providing immersive medtech consulting services focused on commercialization, investment strategy, and finance. Our hands-on execution helps portfolio companies navigate medical device regulatory strategy, FDA 510(k) submission support, and reimbursement strategy for medtech, ensuring they move forward with clarity and achieve meaningful impact.

We're so grateful for our program partnership with Project Medtech. From scouting, screening, and syndicating deals to value-added coaching, connecting, and consulting, the Project Medtech team has always delivered for our members. They bring a rare combination of entrepreneurial grit, process innovation, and fun to dealflow and events. Pointe Angels is more effective, and provides its members with greater value, thanks to this partnership.

David Bloom, Executive Director
Micaela Trexler, PhD, Associate Director
Pointe Angels

The Project Medtech team is a welcome partner for early-stage healthcare companies in the Midwest and beyond. Allowing founders to focus on the things they are good at is an enterprise valuation acceleration tool every startup should use and every investor will appreciate.

Bill Trainor, Managing Director

Mutual Capital Partners

Regulatory & Quality Diligence

UNDERSTAND THE READINESS AND RISK BEHIND THE PRODUCT

For medtech investors, regulatory and quality considerations can materially affect timeline, valuation, and overall investment potential. Project Medtech helps assess regulatory pathways, pre-submission readiness, quality system maturity, and broader compliance considerations so investors can better understand where a company stands and what may be required to move forward successfully.

Core Services

Regulatory Pathway Assessment
Pre-Submission Support
Quality Gap Analysis
Quality Audit Preparation
Quality Management System Implementation

Investment Diligence Evaluation

VET OPPORTUNITIES WITH DEEPER MEDTECH-SPECIFIC INSIGHT

General diligence is not always enough in medtech. Project Medtech helps investors evaluate opportunities through a more specialized lens, bringing together perspectives on market viability, clinical usability, reimbursement, pathway complexity, and broader commercialization realities. This gives investors stronger context for assessing risk, fit, and upside before capital is deployed.

Core Services

Opportunity Assessment
Market Pathway Strategy
Commercialization Strategy
Product Journey Mapping
Reimbursement Strategy & Assessment

Reimbursement & Market Access Insight

EVALUATE WHETHER ADOPTION CAN HAPPEN IN THE REAL WORLD

A promising technology still needs a clear path to reimbursement and market uptake. Project Medtech helps investors assess reimbursement potential, evidence needs, economic value propositions, and stakeholder dynamics that may influence adoption. This adds practical context to diligence and helps surface issues that may not be obvious in a traditional investment review.

Core Services

Reimbursement Strategy & Assessment
Clinical Evidence Strategy
Economic Story Development
Product Journey Mapping

Portfolio Company Support

EXTEND VALUE BEYOND THE INVESTMENT ITSELF

Project Medtech helps funds strengthen their value-added offering by supporting portfolio companies after investment. That support can include commercialization planning, go-to-market strategy, reimbursement guidance, regulatory planning, and broader strategic advising that helps companies build momentum and avoid common pitfalls as they grow.

Core Services

Post-Investment Strategic Support
Commercialization Strategy
Go-to-Market Strategy
Sales Strategy
Marketing Consulting

Financial & Fundraising Readiness

HELP PORTFOLIO COMPANIES PREPARE FOR THE NEXT RAISE OR MILESTONE

Many early-stage companies need stronger financial structure and investor-facing materials even after the initial investment. Project Medtech supports financial modeling, forecasting, dilution analysis, investor readiness, pitch development, and executive summaries to help portfolio companies communicate more credibly and prepare for follow-on capital, partnerships, or strategic conversations.

Core Services

Financial Modeling & Forecasting
Capital Structure & Dilution Analysis
Investor Readiness Assessment
Pitch Deck Development
Executive Summary Development

Sales, Marketing & Commercial Positioning

SUPPORT COMPANIES AS THEY MOVE TOWARD TRACTION AND GROWTH

A strong technology still needs a clear commercial story. Project Medtech helps portfolio companies refine positioning, shape integrated marketing strategies, and develop collateral that communicates product value with greater clarity. This can strengthen market presence, improve stakeholder communication, and help early commercial efforts gain traction.

Core Services

Marketing & Branding Strategy + Execution
PR Strategy
Sales Strategy
Commercialization Strategy
Go-to-Market Strategy

Fund Diligence Support

ADD SPECIALIZED EXTERNAL PERSPECTIVE TO INVESTMENT EVALUATION

Project Medtech serves as a third-party expert resource for investors seeking more confidence in opportunity review. This outside perspective can help validate assumptions, uncover overlooked risks, and sharpen diligence in categories where sector-specific knowledge matters most.

Core Services